Longterm efficacy and safety of two short standardised regimens for the treatment of rifampicinresistant tuberculosis STREAM stage 2 extended followup of an openlabel multicentre randomised noninferiority trial

Simple item page
dc.article.end-page987en
dc.article.start-page975en
dc.citation.doi10.1016/S2213-2600(24)00186-3en
dc.contributor.authorR Goodallen
dc.contributor.authorA Nunnen
dc.contributor.authorS Meredithen
dc.contributor.authorA Bayissaen
dc.contributor.authorMohammed Rassoolen
dc.contributor.authorF Conradieen
dc.contributor.authorT Mwelaseen
dc.contributor.authorE et alen
dc.date.accessioned2025-04-10T08:33:42Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn2213-2600en
dc.identifier.urihttps://hdl.handle.net/10539/44678
dc.journal.titleLongterm efficacy and safety of two short standardised regimens for the treatment of rifampicinresistant tuberculosis STREAM stage 2 extended followup of an openlabel multicentre randomised noninferiority trialen
dc.journal.volume12en
dc.publisherELSEVIER SCI LTDen
dc.titleLongterm efficacy and safety of two short standardised regimens for the treatment of rifampicinresistant tuberculosis STREAM stage 2 extended followup of an openlabel multicentre randomised noninferiority trialen
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
901.18 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download

Collections

Academic Wits Research Outputs (All submissions)